Herbal composition for the treatment of Herpes

A method of treating a subject suffering from symptoms associated with Herpes simplex virus or Human papilloma virus, comprising administering to the subject an effective amount of composition comprising;

• a) aerial part extract of Hypericum mysorense of about 500 mg to 600 mg;
• b) bark extract of Holoptelia integrifolia of about 25 mg to 35 mg;
• c) fruit extract of Terminalia chebula of about 35 mg to 45 mg;
• d) root extract of Glycyrrhiza glabra of about 90 mg to 100 mg;
• e) seed extract of Acacia Catechu of about 35 mg to 40 mg;
• f) leaf extract of Olea europaea of about 50 mg to 60 mg;
• g) petals and rose hips extract of Rosa canina of about 50 mg to 60 mg;
• h) inner bark extract of Tecoma avellanedae of about 50 mg to 60 mg;
• and
• i) oleo resin/gum of Boswellia serratta of about 50 mg to 60 mg, and the composition further comprising pharmaceutical acceptable excipients (q.s);
• wherein, the fruit extract of Terminalia chebula is a cooling transport and allows the antiviral herb Hypericum mysorense and Holoptelia integrifolia to have effect on the viral cells;
• the leaf extracts of Olea europaea relaxes the whole nervous system and accelerates wound healing;
• petals and ripe hips extract of Rosa canina enhances cellular immunity;
• inner bark extract of Tecoma avellanedae helps in quick healing and Oleo resin/gum of Boswellia serratta helps in binding and preservation.

A method of treating a subject suffering from symptoms associated with Herpes simplex virus and Human papilloma virus comprising administering to a subject in need thereof an effective amount of composition comprising;

• a) aerial part extract of Hypericum mysorense of about 500 mg to 600 mg;
• b) bark extract of Holoptelia integrifolia of about 25 mg to 35 mg;
• c) fruit extract of Terminalia chebula of about 35 mg to 45 mg;
• d) root extract of Glycyrrhiza glabra of about 90 mg to 100 mg;
• e) seed extract of Acacia Catechu of about 35 mg to 40 mg;
• f) leaf extract of Olea europaea of about 50 mg to 60 mg;
• g) petals and rose hips extract of Rosa canina of about 50 mg to 60 mg;
• h) inner bark extract of Tecoma avellanedae of about 50 mg to 60 mg;
• i) oleo resin/gum of Boswellia serratta of about 50 mg to 60 mg and
• j) Astaxanthin of about 1 mg to 3 mg, and the composition further comprising pharmaceutical acceptable excipients (q.$);
• wherein, the fruit extract of Terminalia chebula is a cooling transport and allowing the antiviral herb Hypericum mysorense and Holoptelia integrifolia to have effect on the viral cells;
• the leaf extracts of Olea europaea relaxes the whole nervous system and accelerates wound healing;
• petals and ripe hips extract of Rosa canina enhances cellular immunity;
• inner bark extract of Tecoma avellanedae helps in quick healing;
• oleo resin/gum of Boswellia serratta helps in binding and preservation;
• and
• wherein, Astaxanthin transports the antivirals and make them available in the nerve ganglia where the virus resides.